Page last updated: 2024-08-23

mifepristone and Psychotic Disorders

mifepristone has been researched along with Psychotic Disorders in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.67)18.2507
2000's9 (60.00)29.6817
2010's5 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Golier, JA; Yehuda, R1
Howland, RH1
Schatzberg, AF1
Bendall, S; Garner, B; Hetrick, SE; Phillips, LJ1
Belanoff, JK; Blasey, CM; Block, T; Debattista, C; Roe, R1
Belanoff, JK; Blasey, CM; Block, TS; Roe, RL1
Hui, X; Wang, MW; Zhou, CH1
Alva, G; Belanoff, J; Blasey, C; Carpenter, LL; DeBattista, C; Glass, S; Horne, RL; Khan, A1
Nihalani, ND; Schwartz, TL1
de Graaff, M; Dirks, A; Groenink, L; Millan, MJ; Olivier, B; Peeters, BW; Verdouw, PM1
Carroll, BJ; Rubin, RT1
Bilgin, YM; De Herder, WW; Fischer, HR; van der Wiel, HE1
Belanoff, JK; Flores, BH; Kalezhan, M; Schatzberg, AF; Sund, B1
Foeken, K; Lamberts, SW; van der Lely, AJ; van der Mast, RC1

Reviews

5 review(s) available for mifepristone and Psychotic Disorders

ArticleYear
Mifepristone as a therapeutic agent in psychiatry.
    Journal of psychosocial nursing and mental health services, 2013, Volume: 51, Issue:6

    Topics: Affective Disorders, Psychotic; Alcoholism; Antipsychotic Agents; Clinical Trials as Topic; Cocaine-Related Disorders; Hormone Antagonists; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Mental Disorders; Mifepristone; Pituitary-Adrenal System; Psychotic Disorders; Stress Disorders, Post-Traumatic; Weight Gain

2013
Anna-Monika Award Lecture, DGPPN Kongress, 2013: the role of the hypothalamic-pituitary-adrenal (HPA) axis in the pathogenesis of psychotic major depression.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2015, Volume: 16, Issue:1

    Topics: Awards and Prizes; Clinical Trials as Topic; Cognition Disorders; Depressive Disorder, Major; Dexamethasone; Dopamine; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Mifepristone; Pituitary-Adrenal System; Psychotic Disorders; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid

2015
Antiglucocorticoid and related treatments for psychosis.
    The Cochrane database of systematic reviews, 2016, Jan-04, Issue:1

    Topics: Dehydroepiandrosterone; Dexamethasone; Glucocorticoids; Humans; Hypothalamo-Hypophyseal System; Ketoconazole; Mifepristone; Pituitary-Adrenal System; Psychotic Disorders; Randomized Controlled Trials as Topic

2016
Glucocorticoid receptor and treatment of psychotic major depression.
    Yao xue xue bao = Acta pharmaceutica Sinica, 2005, Volume: 40, Issue:11

    Topics: Animals; Brain; Dehydroepiandrosterone; Depressive Disorder, Major; Humans; Metyrapone; Mifepristone; Psychotic Disorders; Pyrimidines; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid

2005
Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression.
    Current opinion in investigational drugs (London, England : 2000), 2007, Volume: 8, Issue:7

    Topics: Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Depressive Disorder, Major; Glucocorticoids; Hormone Antagonists; Humans; Mifepristone; Molecular Structure; Psychotic Disorders

2007

Trials

4 trial(s) available for mifepristone and Psychotic Disorders

ArticleYear
A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction.
    Contemporary clinical trials, 2009, Volume: 30, Issue:4

    Topics: Adult; Antidepressive Agents; Brief Psychiatric Rating Scale; Comorbidity; Depression; Drug Administration Routes; Humans; Mifepristone; Psychotic Disorders; Receptors, Glucocorticoid

2009
Efficacy and safety of mifepristone for the treatment of psychotic depression.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:4

    Topics: Adult; Depressive Disorder; Dizziness; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Mifepristone; Psychotic Disorders; Treatment Outcome

2011
Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.
    Biological psychiatry, 2006, Dec-15, Volume: 60, Issue:12

    Topics: Adult; Aged; Depressive Disorder, Major; Double-Blind Method; Female; Hormone Antagonists; Humans; Male; Middle Aged; Mifepristone; Psychiatric Status Rating Scales; Psychotic Disorders

2006
Rapid reversal of psychotic depression using mifepristone.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:5

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Brief Psychiatric Rating Scale; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Female; Hormone Antagonists; Humans; Hydrocortisone; Male; Middle Aged; Mifepristone; Psychotic Disorders; Time Factors

2001

Other Studies

6 other study(ies) available for mifepristone and Psychotic Disorders

ArticleYear
Mifepristone as a Psychopharmacologic Agent: Consideration of Efficacy, Plasma Levels, and Mechanism of Action.
    Biological psychiatry, 2018, 07-01, Volume: 84, Issue:1

    Topics: Bipolar Disorder; Depression; Depressive Disorder, Major; Humans; Mifepristone; Psychotic Disorders

2018
New treatments for depression with psychosis. Two experimental treatments for depression have shown promise in preliminary studies; one a relatively new drug, the other a familiar hormone.
    The Harvard mental health letter, 2003, Volume: 20, Issue:2

    Topics: Antipsychotic Agents; Depression; Humans; Male; Mifepristone; Psychotic Disorders; Testosterone

2003
CRF1 not glucocorticoid receptors mediate prepulse inhibition deficits in mice overexpressing CRF.
    Biological psychiatry, 2008, Feb-15, Volume: 63, Issue:4

    Topics: Acoustic Stimulation; Adrenalectomy; Animals; Benzodioxoles; Depressive Disorder, Major; Disease Models, Animal; Gene Expression; Genotype; Hormone Antagonists; Infusions, Parenteral; Male; Mice; Mice, Transgenic; Mifepristone; Psychotic Disorders; Receptors, Corticotropin-Releasing Hormone; Receptors, Glucocorticoid; Reflex, Startle; Steroids

2008
Mifepristone in psychotic depression?
    Biological psychiatry, 2008, Jan-01, Volume: 63, Issue:1

    Topics: Depressive Disorder, Major; Hormone Antagonists; Humans; Mifepristone; Psychotic Disorders

2008
Treatment of severe psychosis due to ectopic Cushing's syndrome.
    Journal of endocrinological investigation, 2007, Volume: 30, Issue:9

    Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Drug Therapy, Combination; Etomidate; Female; Hormone Antagonists; Humans; Hydrocortisone; Hypnotics and Sedatives; Lung Neoplasms; Middle Aged; Mifepristone; Psychotic Disorders

2007
Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486).
    Annals of internal medicine, 1991, Jan-15, Volume: 114, Issue:2

    Topics: Acute Disease; Adrenal Gland Neoplasms; Adult; Cushing Syndrome; Female; Glucocorticoids; Humans; Male; Mifepristone; Psychotic Disorders

1991